EQS-News: Asklepios places its first Social Schuldschein loan of EUR 500.0 million

Asklepios places its first Social Schuldschein loan of EUR 500.0 million

• First transaction under the newly established Social Finance Framework
• Issuance proceeds to be used for (re-)financing social projects
• High demand for the Social Schuldschein loan enabled a doubling of the issuance volume

Hamburg, November 6, 2024. Asklepios Kliniken GmbH & Co. KGaA successfully refinanced itself through a Social Schuldschein loan issuance amounting to EUR 500.0 million. The new Schuldschein was placed with maturities of 3, 5, 7, and 10 years among both existing and new investors.

The structure as a Social Schuldschein loan, through which the issuance proceeds under the newly established Social Finance Framework can be allocated to the area of social healthcare infrastructure, met with significant investor interest. Despite challenging market conditions, the issuance volume was doubled from the initial EUR 250.0 million to a total of EUR 500.0 million.

In addition to the official Schulschein marketing, existing investors with maturities in 2025 had the opportunity to reinvest their Schuldschein holdings early in the new Social Schuldschein through an exchange offer.

“The new Social Schuldschein loan enables us to finance investments in our healthcare infrastructure, thus ensuring a clear allocation of funds to the social benefit of our daily actions as a healthcare group,” says Hafid Rifi, Chief Financial Officer of the Asklepios Group. "Moreover, establishing the Asklepios Social Finance Framework marks an important step in further integrating our sustainability ambitions into our financing strategy," Rifi continues. "We are pleased with the strong demand from both existing and new investors, underscoring trust in our business model and corporate strategy once again."

“With 35% of the issuance volume, the share of foreign investors was high once again,” adds Benedikt Brörmann, Group Head of Corporate Finance & Treasury at Asklepios. "We were also able to place approximately 20% of the issuance volume with new investors," says Brörmann. “The success of this year’s transaction was due to the compelling Asklepios credit story combined with the right marketing strategy and timing.”

The placement of the Social Schuldschein loan was supported by Landesbank Hessen-Thüringen, ING Bank, Landesbank Baden-Württemberg, and UniCredit as arrangers. Linklaters LLP acted as Asklepios' legal advisor.

About Asklepios

Asklepios Kliniken is one of the leading private operators of hospitals and healthcare facilities in Germany. The hospital group stands for highly qualified care for its patients with a clear commitment to medical quality, innovation and social responsibility. On the basis of this, Asklepios has developed dynamically since it was founded more than 35 years ago. The group currently has 164 healthcare facilities across Germany. These include acute hospitals at all levels of care, university hospitals, specialist clinics, psychiatric and forensic facilities, rehabilitation clinics, care homes and medical centres. In the financial year 2023, over 3.5 million patients were treated in Asklepios Group facilities. The company has more than 68,000 employees.

 For inquiries:

Creditor Relations contact:
Stefan Sinzel
Manager Corporate Finance
Asklepios Kliniken GmbH & Co. KGaA
Debusweg 3 – 61462 Königstein-Falkenstein
Tel: +49 6174 9011-96
E-Mail: [email protected]

Press contact:
Rune Hoffmann
Head of Corporate Communications & Marketing
Asklepios Kliniken GmbH & Co. KGaA
Rübenkamp 226 – 22307 Hamburg
Tel.: +49 40 1818-82 6630
Fax: +49 40 1818-82 6639
E-Mail: [email protected]

Visit Asklepios on the internet, Facebook, or YouTube:
www.asklepios.com
www.asklepios.com/konzern/gesundheitsmagazin
www.facebook.com/asklepioskliniken
www.youtube.com/asklepioskliniken

Subscribe to the Asklepios newsletter:
https://www.asklepios.com/konzern/newsletter-anmeldung/
Nursing Blog: „Wir sind Pflege“